Oncologists should re-evaluate cancer treatments near end of life
Yale Cancer Center/Smilow Cancer HospitalSystemic treatment of cancer patients near end of life does not improve survival rates, according to a new study from researchers at Yale Cancer Center (YCC) and The University of Texas MD Anderson Cancer Center. The study, which joins a growing body of research on end-of-life cancer treatment, published May 16 in JAMA Oncology.